Timing of Calculation. The lending limit base will be calculated on a monthly basis as of the preceding month end. [58 FR 40321, July 28, 1993, as amended at 59 FR 37403, July 22, 1994; 64 FR 34517, June 28, 1999; 70 FR 35348, June 17, 2005; 70 FR 53907, Sept. 13, 2005]
Timing of Calculation. CAPNet shall calculate commissions on the 12th day of each month and the 3rd day prior to the end of each month.
Timing of Calculation. The NSR shall be calculated as at the end of each quarter of the applicable fiscal year.
Timing of Calculation. The lending limit base will be calculated on a monthly basis as of the preceding month end.
Timing of Calculation. T h e le n di n g li m i t b a se will be c a xx x x x x ed o n a m o n t h l y b a s i s a s of t h e p r ecedi n g m o n t h e n d. [58 F R 40321, J u l y 28, 1993, a s a m e n ded a t 59 F R 37403, J u l y 22, 1994; 64 F R 34517, J un e 28, 1999; 70 F R 35348, J un e 17, 2005; 70 F R 53907, S ep t . 13, 2005]
( a) Farm Credit Ban ks. No F a r m Cr ed- i t B a n k m a y m a k e o r disco un t a lo a n t o a bo rr owe r , if t h e co n solid a t xx x x x un t of a ll lo a n s o u t s t a n di n g a n d un disb ur sed co mm i t m e n t s t o t h a t bo r - r owe r exceed 25 pe r ce n t of t h e b a n k’s le n di n g a n d le a s i n g li m i t b a se.
Timing of Calculation. BioSphere shall calculate and communicate to DuPont the Cost Saving Payments (and all underlying calculations and components) within [**] days of the end of each calendar quarter.
Timing of Calculation. The Operating Metrics Scorecard for each Applicable Phase will be calculated at the end of each Measurement Period. The calculation will be based on the [**] of the applicable Measurement Period for each Applicable Phase, and will [**] on the first day of each subsequent Fiscal Year [**]. The Operating Metrics will be measured quarterly, on a cumulative basis within any single Fiscal Year.
Timing of Calculation. Exit Fees shall be calculated as of the Termination Date.
Timing of Calculation. The Operating Metrics Scorecard for each Eligible Recipient will be calculated at the end of each Measurement Period. For Income Statement Operating Metrics the calculation will be a rolling average effective from the first day of the applicable Eligible Recipient’s fiscal year, and will reset annually on the first day of each subsequent fiscal year of such Eligible Recipient (e.g. an Eligible Recipient’s third fiscal quarter measurement would reflect fiscal year to date performance for the first three quarters of the fiscal year). The Income Statement Operating Metrics will be measured quarterly, on a cumulative basis within any single Ascension Fiscal Year and the resulting Income Statement Incentive Payment will be paid quarterly, independent of the measurement, billing and payment of the Balance Sheet Operating Metrics and the Balance Sheet Incentive Payment related thereto. For Balance Sheet Operating Metrics the calculation of Actual Performance will reflect active AR values at the end of each Measurement Period which will be deemed final for each quarter. The Balance Sheet Operating Metrics will be measured quarterly, on a non-cumulative basis and the resulting Balance Sheet Incentive Payment will be paid quarterly, in each case independent of the measurement, billing, and payment of the Income Statement Operating Metrics. The table below provides a summary of key concepts outlined above.
1) Metric Removed
2) [*****] [*****] [*****] [*****]
3) Metric Removed
4) [*****] [*****] [*****] [*****]
5) [*****] [*****] [*****] [*****]
6) Metric Removed
Timing of Calculation. RCA Scorecard metrics will be calculated at the end of each Measurement Period (i.e. quarterly). For Income Statement (I/S) metrics the calculation will be a rolling average effective from the Effective Date of the Supplement Term, and will reset [**] on the [**] of the Effective Date of the Supplement Term (e.g. [**]). For Balance Sheet (B/S) metrics the calculation will reflect active [**] which will be deemed final for each quarter. The table below provides a summary of key concepts outlined above. ASCENSION HEALTH CONFIDENTIAL Exhibit 4-B Page 5
